| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/12/2004 | US20040028751 Compositions for preventing or ameliorating multiple risk factor syndromes |
| 02/12/2004 | US20040028722 Microbial cellulose wound dressing for treating chronic wounds |
| 02/12/2004 | US20040028691 Administering eicosapentaenoic acid, docosahexaenoic acid |
| 02/12/2004 | US20040028684 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/12/2004 | US20040028658 Methods of organ regeneration |
| 02/12/2004 | US20040028644 Synergistic mixture |
| 02/12/2004 | US20040028619 Antiinflammatory agents; bronchodilator agents; antihistamines; respiratory system disorders |
| 02/12/2004 | DE10233817A1 Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted Diarylheterocyclen, processes for their preparation and their use as medicaments |
| 02/12/2004 | DE10233412A1 Neue Verbindungen als Histondeacetylase-Inhibitoren New connections as histone deacetylase inhibitors |
| 02/12/2004 | CA2494801A1 Medicinal composition containing hmg-coa reductase inhibitor |
| 02/12/2004 | CA2494421A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 02/12/2004 | CA2494408A1 Method and compounds for promoting healing and reducing inflammation |
| 02/12/2004 | CA2494281A1 Sustained release formulations of metformin |
| 02/12/2004 | CA2494114A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 02/12/2004 | CA2493618A1 Nitrosated proton pump inhibitors, compositions and methods of use |
| 02/12/2004 | CA2493551A1 Aminoalkyl-substituted aryl compounds and their use as sodium channel blockers |
| 02/12/2004 | CA2493253A1 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 02/12/2004 | CA2397684A1 Mitochondrially targeted antioxidants |
| 02/11/2004 | EP1388537A1 Arginine derivatives |
| 02/11/2004 | EP1388535A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/11/2004 | EP1388534A2 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
| 02/11/2004 | EP1388352A1 Use of a ppar-alpha agonist to treat patients suffering from weight gain associated with a ppar-gamma agonist treatment |
| 02/11/2004 | EP1388351A1 Use of fibrate to treat weight gain associated with rosiglitazone treatment |
| 02/11/2004 | EP1388344A1 Composition comprising Salvia Miltiorrhizae, Ginseng, Borneol for treating heart disease, and cerebrovascular diseases |
| 02/11/2004 | EP1388342A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 02/11/2004 | EP1388341A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/11/2004 | EP1388340A1 Compositions for transmucosal administration containing coenzyme q as the active ingredient |
| 02/11/2004 | EP1387889A2 Kinases and phosphatases |
| 02/11/2004 | EP1387888A2 Nucleic acid-associated proteins |
| 02/11/2004 | EP1387854A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 02/11/2004 | EP1387843A1 Method for obtaining pioglitazone as an antidiabetic agent |
| 02/11/2004 | EP1387830A1 Novel 4-anilinoquinoline-3-carboxamides |
| 02/11/2004 | EP1387821A2 Estrogen receptor modulators |
| 02/11/2004 | EP1387713A1 Method of preventing type 2 diabetes with aerosolized insulin |
| 02/11/2004 | EP1387680A1 Benzimidazole derivatives as therapeutic agents |
| 02/11/2004 | EP1387679A1 Sulfonamides |
| 02/11/2004 | EP1387675A2 Liquid formulation of metformin |
| 02/11/2004 | EP1328282A4 Efficient method for producing compositions enriched in anthocyanins |
| 02/11/2004 | EP1300394B1 Method for the production of a water-dispersible formulation containing carotenoids |
| 02/11/2004 | EP1180944B1 Compositions containing creatine in suspension |
| 02/11/2004 | EP1144393B1 Benzoxazole derivatives for use as integrin inhibitors |
| 02/11/2004 | EP1086113B1 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 02/11/2004 | EP0994716B1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body |
| 02/11/2004 | EP0859608B1 Treating niddm with rxr agonists |
| 02/11/2004 | CN1474818A Preventive or therapeutic medicines for diabetes, containing fused heterocycle compounds or their salts |
| 02/11/2004 | CN1474812A (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitor |
| 02/11/2004 | CN1474810A Substituted urea neuropeptide YY5 antagonists |
| 02/11/2004 | CN1474809A Cyanopyrolidine derivatives |
| 02/11/2004 | CN1474805A 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/11/2004 | CN1474699A Remedies for diabetes |
| 02/11/2004 | CN1474698A Formulation containing phosphate derivatives of electron transfer agents |
| 02/11/2004 | CN1474697A Complexes of phosphate derivatives |
| 02/11/2004 | CN1474696A Novel pharmacentical compositions with anti-diabetic activity and method for preparing same |
| 02/11/2004 | CN1474690A Synergestic combinations comprising renin inhibitor for cardiovascular diseases |
| 02/11/2004 | CN1474688A Novel uses of combined selective dopamine D2 receptor antagonists and 5-HT1A receptor agonists |
| 02/11/2004 | CN1474687A Mdeicine based on anti-hyperglycaemic microcapsules with prolonged release |
| 02/11/2004 | CN1473852A Trivalent chromium composition and its use |
| 02/11/2004 | CN1473838A Extracting and refining process for alfalfa saponin and alfalfa saponin preparation |
| 02/11/2004 | CN1473607A Composition for preventing and treating hyperlipidemia |
| 02/11/2004 | CN1473600A Medicine for pancreas and kidney |
| 02/11/2004 | CN1473589A Fat reducing anti-senility health article |
| 02/11/2004 | CN1473579A Oral liquid for treating diabetes and its preparing method |
| 02/11/2004 | CN1473578A Hypoglycemic tea |
| 02/11/2004 | CN1473567A Combined therapeutic method including acrivastine and antihypertensive |
| 02/11/2004 | CN1473566A Combined therapeutic method including acrivastine and antihypertensive |
| 02/11/2004 | CN1137900C Extracting process of polygonapolyose |
| 02/11/2004 | CN1137894C Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 02/11/2004 | CN1137889C Novel tricycloacylamide compound, its preparation method and medicinal composition containing them |
| 02/11/2004 | CN1137888C Inhibitor of cysteninyl aspartic acid proteinase |
| 02/11/2004 | CN1137884C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use |
| 02/11/2004 | CN1137720C Chinese medicine for treating diabetes and its complication |
| 02/11/2004 | CN1137706C Medicine for treating hyperlipemia |
| 02/11/2004 | CN1137700C Process for preparing medicine (sanpigualou powder) to treat diabetes |
| 02/11/2004 | CN1137684C Pharmaceutical composition stabilized with basic agent |
| 02/10/2004 | US6689938 Administering an antagonist of melanocortin stimulating hormone (msh) biological activity. |
| 02/10/2004 | US6689922 Vitamin D analogues |
| 02/10/2004 | US6689909 Substituted N-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 02/10/2004 | US6689906 Bicyclic amino acids as pharmaceutical agents |
| 02/10/2004 | US6689889 Using n-acryloxyphenylaniline neomenthylamide |
| 02/10/2004 | US6689888 Processes and intermediates useful in preparing β3-adrenergic receptor agonists |
| 02/10/2004 | US6689804 Imidazo-imidazole |
| 02/10/2004 | US6689800 β3-adrenergic receptor agonist crystal forms, processes for the production thereof, and uses thereof |
| 02/10/2004 | US6689797 Tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 02/10/2004 | US6689778 2-phenylamino-5-isoxazo-4-yl-pyrimidine derivatives |
| 02/10/2004 | US6689766 Also for treating malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis, dermatitis, hypercalcemia, hypoparathyroidism and metabolic disorder of cartilage. |
| 02/10/2004 | US6689764 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 02/10/2004 | US6689751 Peptide comprising amino acid sequence 15 or 83 with alanine or alpha-aminoisobutyrate substitution |
| 02/10/2004 | US6689745 Agent for ameliorating pancreatic function disorder |
| 02/10/2004 | US6689741 Biocompatible polymers, process for their preparation and compositions containing them |
| 02/10/2004 | US6689570 Antibody or antigen-binding sequences for use in the treatment of inflammatory bowel disease |
| 02/10/2004 | US6689383 Significantly improves absorption capability |
| 02/10/2004 | US6689359 Ligands, including antibodies, showing reactivity against endocrine cells |
| 02/10/2004 | US6689299 Process for producing solid creatine dosage forms and dosage forms obtainable thereby |
| 02/10/2004 | CA2372576C Pharmaceutical composition of fenofibrate presenting a high biodisponibility and its preparation process |
| 02/10/2004 | CA2108903C Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 02/10/2004 | CA2079447C Sustained drug release through topical application of bioadhesive liposomes |
| 02/05/2004 | WO2004011680A1 Regulated aptamer therapeutics |
| 02/05/2004 | WO2004011661A1 Novel physiologically active substances |
| 02/05/2004 | WO2004011640A1 Three-dimensional structure of dipeptidyl peptidase iv |
| 02/05/2004 | WO2004011621A2 Multi-step method for the differentiation of insulin positive, glucose |